Chronic liver disease is a major complication of cystic fibrosis (CF) and factors other than the deletion of ΔF508 (which causes CF) may control the development of liver damage. In May
Gabolde
Immunodeficiency characteristically associated with MBL variants could increase the hepatotoxic damage from viruses and may therefore facilitate the degradation of the liver in these patients.